a Sanofi company, announced today that selected artwork from Expression
of Hope III will be featured through a travelling exhibit and online
gallery. Expression of Hope is a global disease awareness program
featuring works of art created by the community of people...
a Sanofi company, today announced that it has received the 2015 Industry
Innovation Award from the National Organization for Rare
Disorders (NORD) in recognition of Cerdelga® (eliglustat)
capsules. Genzyme was selected for the company’s work in bringing an...
a Sanofi company, announced today that the Food and Drug Administration
(FDA) has granted Fast Track designation for the development of
GZ/SAR402671, a new investigational oral substrate reduction therapy for
the treatment of Fabry disease.
company, announced that new magnetic resonance imaging (MRI) data from
the Lemtrada® (alemtuzumab) clinical development
program will be presented today at the 67th American Academy of
Neurology (AAN) Annual Meeting.